Hydroxychloroquine in children with proliferative lupus nephritis: a randomized clinical trial.
Fatma Sayed GheetHeba El-Sayed DawoudWaleed Ahmed El-ShahabyShymaa Mohamed ElrifaeyHend Hassan AbdelnabiPublished in: European journal of pediatrics (2023)
• This pilot randomized clinical trial assessed the efficacy and adverse effects of HCQ in children with proliferative LN. • HCQ had numerous advantages for LN, including rapid and sustained remission, antilipidemic effect, and rapid improvement of kidney functions.